EP Patent

EP1646393A1 — A stable clozapine suspension formulation

Assigned to Douglas Pharmaceuticals Ltd · Expires 2006-04-19 · 20y expired

What this patent protects

A physicochemically stable aqueous composition including clozapine suspension.

USPTO Abstract

A physicochemically stable aqueous composition including clozapine suspension.

Drugs covered by this patent

Patent Metadata

Patent number
EP1646393A1
Jurisdiction
EP
Classification
—
Expires
2006-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Douglas Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.